The international cancer conference ASCO was held in Chicago this weekend. ASCO is one of the most important cancer conferences in world where the latest in cancer research is presented. The conference is also an important meeting place and all the major pharmaceutical companies are represented.
Recruitment of new drugs to IMPRESS
Recruitment of more clinical studies to Norway and inclusion of new drugs to IMPRESS-Norway requires that global decision-makers in the different pharma companies wants to invest in Norway. Åslaug Helland (PI in IMPRESS-N) used ASCO to meet global representatives from several companies in individual meetings. In the meetings she presented the good recruitment figures from IMPRESS-Norway and how Norway facilitates clinical studies through, among other things, the infrastructure for precision diagnostics (InPreD), the public-private partnership CONNECT and NorTrials.
The industry meetings was set up and organized by the local representatives from the different pharmaceutical companies. Recruitment of new drugs to IMPRESS and / or more clinical studies to Norway requires close collaboration between the local company representatives and the hospitals. Through the meetings at ASCO, we hope to lay a good foundation for further promotion of IMPRESS and Norway.
The news was first mentioned in DagensMedisin which you can read here.